Sparta Commercial Services (SRCO) 10-K 15 Aug 22 2022 FY Annual report Financial data

Cover

Cover - USD ($)	12 Months Ended
	Apr. 30, 2022	Aug. 15, 2022
Cover [Abstract]
Document Type	10-K
Amendment Flag	false
Document Annual Report	true
Document Transition Report	false
Document Period End Date	Apr. 30, 2022
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2022
Current Fiscal Year End Date	--04-30
Entity File Number	0-9483
Entity Registrant Name	SPARTA COMMERCIAL SERVICES, INC.
Entity Central Index Key	0000318299
Entity Tax Identification Number	30-0298178
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	555 Fifth Avenue
Entity Address, Address Line Two	14th Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10017
City Area Code	(212)
Local Phone Number	239-2666
Title of 12(b) Security	Common Stock, par value $0.001
Trading Symbol	SRCO
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Public Float	$ 978,241
Entity Common Stock, Shares Outstanding		17,501,298
Documents Incorporated by Reference	None
Auditor Firm ID	6285
Auditor Name	Boyle CPA, LLC
Auditor Location	Red Bank, NJ

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Apr. 30, 2022	Apr. 30, 2021
Current Assets
Cash and cash equivalents	$ 317	$ 396
Accounts receivable		469
Inventory	8,422	13,823
Other current assets
Total Current Assets	8,739	14,688
Property and equipment, net of accumulated depreciation and amortization of $213,262 and $213,262, respectively
Other assets		9,628
Deposits	9,000	9,000
Total assets	17,739	33,316
Current Liabilities
Bank overdraft	27,202	49,041
Accounts payable and accrued expenses	4,354,129	3,627,831
Short Term Loan	141,585	409,013
Current portion notes payable	5,250,084	4,680,275
Deferred revenue	13,385	13,946
Derivative liabilities	9,549,640	3,446,738
Total Current Liabilities	19,336,025	12,226,844
Loans payable-related parties	432,403	432,403
Total Long Term Liabilities	432,403	432,403
Total liabilities	19,768,428	12,659,247
Stockholders’ Deficit:
Common stock, $0.001 par value; 750,000,000 shares authorized, and 15,128,005 and 9,809,877 shares issued and outstanding, respectively	15,128	9,810
Common stock to be issued 8,916,805 and 1,214,528 respectively	8,292	1,215
Additional paid-in-capital	53,210,921	51,351,156
Accumulated deficit	(73,984,686)	(64,993,250)
Total deficiency in stockholders’ equity	(20,734,864)	(13,612,930)
Non-controlling interest	984,175	986,999
Total Deficit	(19,750,689)	(12,625,931)
Total Liabilities and Deficit	17,739	33,316
Series A convertible preferred stock [Member]
Stockholders’ Deficit:
Preferred stock value	12,500	12,500
Series B convertible preferred stock [Member]
Stockholders’ Deficit:
Preferred stock value
Series C redeemable convertible preferred stock [Member]
Stockholders’ Deficit:
Preferred stock value	2,363	4,145
Series D redeemable convertible preferred stock [Member]
Stockholders’ Deficit:
Preferred stock value	$ 618	$ 1,494

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	Apr. 30, 2022	Apr. 30, 2021
Accumulated depreciation and amortization	$ 213,262	$ 213,262
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares designated	10,000,000	10,000,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	750,000,000	750,000,000
Common stock shares issued	15,128,005	9,809,877
Common stock shares outstanding	15,128,005	9,809,877
Common stock to be issued	8,916,805	1,214,528
Series A convertible preferred stock [Member]
Preferred stock, par value	$ 100	$ 100
Preferred stock, shares designated	35,850	35,850
Preferred stock, shares issued	125	125
Preferred stock, shares outstanding	125	125
Series B convertible preferred stock [Member]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares designated	1,000	1,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Preferred stock, liquidation and redemption value per share	$ 10,000	$ 10,000
Series C redeemable convertible preferred stock [Member]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares designated	200,000	200,000
Preferred stock, shares issued	4,145	4,145
Preferred stock, shares outstanding	4,145	4,145
Preferred stock, liquidation and redemption value per share	$ 10	$ 10
Series D redeemable convertible preferred stock [Member]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares designated	2,000,000	2,000,000
Preferred stock, shares issued	1,494	4,494
Preferred stock, shares outstanding	1,494	4,494
Preferred stock, liquidation and redemption value per share	$ 1	$ 1

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Apr. 30, 2022	Apr. 30, 2021
Revenue
Total Revenue	$ 245,469	$ 259,731
Less Cost of goods sold	42,161	60,986
Gross profit	203,308	198,745
Operating expenses:
General and administrative	1,199,416	1,394,881
Research and development	217,138
Total operating expenses	1,470,554	1,394,881
Loss from operations	(1,267,246)	(1,196,136)
Other (income) expense:
Other income	(11,956)	(7,690)
Forgiveness of debt		(125,328)
Financing cost	601,279	723,003
Amortization of debt discount	0
Loss (gain) in changes in fair value of derivative liability	7,132,043	504,599
Total other (income) expense	7,721,366	1,094,584
Net income (loss)	(8,988,614)	(2,290,720)
Net loss (income) attributed to non-controlling interest	2,823	(12,748)
Preferred dividend		(191)
Net income (loss) attributed to common stockholders	$ (8,991,437)	$ (2,303,659)
Basic and diluted loss per share:
Loss from continuing operations attributable to Sparta Commercial Services, Inc. common stockholders	$ (0.66)	$ (0.37)
Loss from discontinued operations attributable to Sparta Commercial Services, Inc. common stockholders		0
Net loss attributable to Sparta Commercial Services, Inc. common stockholders	$ (0.66)	$ (0.37)
Weighted average shares outstanding	13,686,995	6,270,929
Information Technology [Member]
Revenue
Total Revenue	$ 219,404	$ 245,675
New World Health Brands [Member]
Revenue
Total Revenue	$ 26,065	$ 14,056

Consolidated Statements of Defi

Consolidated Statements of Deficit - USD ($)	12 Months Ended
	Apr. 30, 2022	Apr. 30, 2021
Balance value	$ (12,625,931)	$ 11,591,617
Issuance of Preferred and Common Stock for Cash		235,502
Conversion of Accrued Compensation to Series D Preferred Stock		311,363
Options issued for compensation and accrued compensation		621,665
Conversion of Preferred to common shares	1,658,714
Conversion of convertible notes	25,000	50,000
Issuance of preferred shares	(321,019)
Issuance of common shares for cash	510,000
Shares issued for services	159,011	25,319
Stocks issued for settlement of payables	25,063
Stocks issued for equity	59,711
Stocks issued from to be issued	(246,978)
Preferred dividend		(191)
Net income (loss)	(8,994,260)	(2,277,972)
alance value	(19,750,689)	(12,625,931)
Common Stock [Member]
Balance value	$ 9,810	$ 9,433
Beginning balance, shares	9,809,877	9,433,282
Conversion of Preferred to common shares	$ 3,194
Conversion of Preferred to common, shares	3,194,418
Conversion of convertible notes	$ 125	$ 250
Conversion of convertible notes, shares	125,000	250,000
Shares issued for services	$ 732	$ 127
Shares issued for services, shares	731,623	126,595
Stocks issued for settlement of payables	$ 427
Stocks issued for settlement of payables, shares	427,235
Stocks issued for equity	$ 355
Stocks issued for equity, shares	355,000
Stocks issued from to be issued	$ 485
Stocks issued from tobe issued, shares	484,852
Net income (loss)
alance value	$ 15,128	$ 9,810
Ending balance, shares	15,128,005	9,809,877
Common Stock to be Issued [Member]
Balance value	$ 1,215	$ 848
Beginning balance, shares	1,214,528	847,865
Issuance of Preferred and Common Stock for Cash		$ 367
Issuance of Preferred and Common Stock for Cash, shares		366,663
Conversion of Preferred to common shares	$ 995
Conversion of Preferred to common, shares	995,500
Conversion of convertible notes
Issuance of preferred shares	$ (2,350)
Issuance of preferred, shares	(1,725,176)
Issuance of common shares for cash	$ 8,917
Issuance of common shares for cash, shares	8,916,805
Stocks issued from to be issued	$ (485)
Stocks issued from tobe issued, shares	(484,852)
Net income (loss)
alance value	$ 8,292	$ 1,215
Ending balance, shares	8,916,805	1,214,528
Additional Paid-in Capital [Member]
Balance value	$ 51,351,156	$ 50,120,928
Issuance of Preferred and Common Stock for Cash		234,995
Conversion of Accrued Compensation to Series D Preferred Stock		311,001
Options issued for compensation and accrued compensation		621,665
Conversion of Preferred to common shares	1,656,493
Conversion of convertible notes	24,875	49,750
Issuance of preferred shares	(317,979)
Issuance of common shares for cash	501,083
Shares issued for services	158,279	25,192
Stocks issued for settlement of payables	24,636
Stocks issued for equity	59,356
Stocks issued from to be issued	(246,978)
Net income (loss)
alance value	53,210,921	51,351,156
Retained Earnings [Member]
Balance value	(64,993,250)	(62,702,339)
Preferred dividend		(191)
Net income (loss)	(8,991,437)	(2,290,720)
alance value	(73,894,687)	(64,993,250)
Noncontrolling Interest [Member]
Balance value	986,999	974,251
Conversion of convertible notes
Net income (loss)	(2,823)	12,748
alance value	984,176	986,999
Series A Preferred Stock [Member] | Preferred Stock [Member]
Balance value	$ 12,500	$ 12,500
Beginning balance, shares	125	125
Net income (loss)
alance value	$ 12,500	$ 12,500
Ending balance, shares	125	125
Series C Preferred Stock [Member] | Preferred Stock [Member]
Balance value	$ 4,145	$ 4,005
Beginning balance, shares	4,132,269	4,132,129
Issuance of Preferred and Common Stock for Cash		$ 140
Issuance of Preferred and Common Stock for Cash, shares		140
Conversion of Preferred to common shares	$ (1,501)
Conversion of Preferred to common, shares	(1,688,269)
Conversion of convertible notes
Issuance of preferred shares	$ (281)
Issuance of preferred, shares	(281,000)
Net income (loss)
alance value	$ 2,363	$ 4,145
Ending balance, shares	2,163,000	4,132,269
Series D Preferred Stock [Member] | Preferred Stock [Member]
Balance value	$ 1,494	$ 1,132
Beginning balance, shares	1,494,962	1,132,962
Conversion of Accrued Compensation to Series D Preferred Stock		$ 362
Conversion of Accrued Compensation to Series D Preferred Stock, shares		362,000
Conversion of Preferred to common shares	$ (467)
Conversion of Preferred to common, shares	(467,551)
Conversion of convertible notes
Issuance of preferred shares	$ (409)
Issuance of preferred, shares	(409,000)
Net income (loss)
alance value	$ 618	$ 1,494
Ending balance, shares	618,411	1,494,962

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Apr. 30, 2022	Apr. 30, 2021
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (8,988,614)	$ (2,290,720)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Loss (Gain) from change in fair value of derivative liabilities	6,102,902	644,613
Amortization of debt discount		(312,049)
Non-cash financing cost	59,465	723,003
Forgiveness of debt	786,091	382,931
Stock based compensation	159,009	464,718
Changes in operating assets and liabilities
Accounts receivable	469	951
Inventory	5,401	9,508
Other assets	9,628	470
Accounts payable and accrued expenses	695,589	(299,504)
Deferred revenue	(561)	(2,308)
Net cash used in operating activities	(1,170,621)	(678,387)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of equipment
Net cash (used in) investing activities
CASH FLOWS FROM FINANCING ACTIVITIES
Bank overdraft	(21,839)	34,268
Proceeds from sale of stock	890,000	235,502
Net Proceeds from notes payable	302,381	409,013
Proceeds from related party notes
Payments on related party notes
Net cash provided by financing activities	1,170,542	678,783
Net (decrease) increase in cash	(79)	396
Cash and cash equivalents, beginning of period	396
Cash and cash equivalents , end of period	317	396
Cash paid for:
Income taxes

SUMMARY OF ACCOUNTING POLICIES

SUMMARY OF ACCOUNTING POLICIES	12 Months Ended
	Apr. 30, 2022
Accounting Policies [Abstract]
SUMMARY OF ACCOUNTING POLICIES	NOTE A – SUMMARY OF ACCOUNTING POLICIES A summary of the significant accounting policies applied in the preparation of the accompanying financial statements follows. Business Sparta Commercial Services, Inc. (“Sparta,” “we,” “us,” or the “Company”) is a Nevada corporation serving four markets. Sparta is a technology company that develops, markets and manages business websites and mobile applications (mobile apps) for smartphones and tablets. The Company also owns and manages websites which sell on-demand motorcycle, recreational vehicle, power-sport vehicle and truck title history reports for consumers, retail dealers, auction houses, insurance companies and banks/finance companies. Lastly, since 2007, Sparta has administered leasing programs nationwide for local and/or state agencies seeking to finance municipal vehicles and equipment. The Company also introduced a new business line in the rapidly expanding Hemp-CBD (cannabidiol) market. In 2016, the Company changed the name of its majority-owned subsidiary Specialty Reports, Inc., to iMobile Solutions, Inc. The new name reflects the Company’s strategic evolution and focus on the growing mobile application market domestically. Sparta’s mobile application (mobile app) offerings have broadened our base beyond our original base of vehicle dealers to include a wide range of businesses including, but not limited to, agriculture dealerships, racetracks, private clubs, country clubs, restaurants and grocery stores. We also offer a private label version of our mobile app framework to enable other businesses to offer custom apps to their customers. The Company also designs, launches, maintains, and hosts websites for businesses. We provide specific, tailored action plans for our clients’ websites that include services such as eCommerce, CRM (Customer Relationship Management) development and integration, ordering system creation and integration, SEO (search engine optimization), social media marketing, and online reviews to improve their presence online. In addition, we offer text messaging services which are vital for businesses’ marketing, retention and loyalty strategies. Our text messaging platform allows our clients to easily manage, schedule, and analyze text message performance. The Company’s vehicle history reports include Cyclechex (Motorcycle History Reports at www.cyclechex.com www.rvchecks.com www.truckchex.com Sparta also administers a Municipal Leasing Program for local and/or state agencies throughout the country who are seeking a better and more economical way to finance their essential equipment needs, including police motorcycles, cruisers, buses, fire trucks, and EMS equipment. We are continuing to expand our roster of equipment manufacturers and the types of equipment we lease. New World Health Brands, Inc. (NWHB) was formed in April 2019 as a subsidiary and new business line of Sparta Commercial Services, Inc. While anticipating, and with the passing of the 2018 Farm Bill, which resulted in the removal of hemp (CBD) from Schedule 1 of the Controlled Substances Act. Sparta’s management recognized a substantial potential business opportunity in the rapidly expanding Industrial Hemp-CBD (Cannabinol) market in the United States. During 2019-2020, management sourced, developed and lab tested 5 CBD product categories totaling 31 products, procured product packaging, labeling, implemented fulfillment and launched an on-line B2C website, www.newworldhealthcbd.com Sparta’s newest subsidiary, Sparta Crypto, Inc., www.SpartaCrypto.com Sparta’s offices are located at 555 Fifth Avenue, 14 th www.spartacommercial.com We identify our ongoing information technology business in two reporting groups: mobile apps/websites and vehicle history reports, both of which operate under our wholly owned subsidiary, iMobile Solutions, Inc. The latest product offering, via www.newworldhealthcbd.com, offering a full array of hemp-derived CBD products, is contained in our subsidiary, New World Health Brands, Inc. Principles of Consolidation The consolidated financial statements include the accounts of the Company and its majority owned subsidiary. All material intercompany transactions and balances have been eliminated in consolidation. The third party ownership of the Company’s subsidiary is accounted for as noncontrolling interest in the consolidated financial statements. Changes in the noncontrolling interest are reported in the statement of stockholders’ deficit. Estimates The preparation of the financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates. Revenue Recognition During the first quarter of 2018, the Company adopted ASU 2014-09, Revenue from Contracts with Customers (Topic 606) The Company acts as a principal in its revenue transactions as the Company is the primary obligor in the transactions. Revenues from mobile app products and New World Health Brands products are generally recognized upon delivery. Revenues from History Reports are generally recognized upon delivery / download. Prepayments received from customers before delivery (if any) are recognized as deferred revenue and recognized upon delivery. The Company records deferred revenues when cash payments are received or due in advance of our performance, including amounts which are refundable. The following table presents our revenues disaggregated by revenue source: SCHEDULE OF DISAGGREGATION REVENUE 2022 2021 Year Ended April 30, 2022 2021 Information Technology $ 219,404 $ 245,675 New World Health Brands 26,065 14,056 Revenues $ 245,469 $ 259,731 Cash Equivalents For the purpose of the accompanying financial statements, all highly liquid investments with a maturity of three months or less are considered to be cash equivalents. Website Development Costs The Company recognizes website development costs in accordance with ASC 350-50, “Accounting for Website Development Costs.” Fair Value Measurements The Company adopted ASC 820, “Fair Value Measurements .” ● Level 1 — ● Level 2 — ● Level 3 — This hierarchy requires the Company to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value. For some products or in certain market conditions, observable inputs may not always be available. Income Taxes We utilize ASC 740 “ Income Taxes The Company recognizes the impact of a tax position in the financial statements only if that position is more likely than not of being sustained upon examination by taxing authorities, based on the technical merits of the position. Our practice is to recognize interest and/or penalties related to income tax matters in income tax expense. Stock Based Compensation We account for our stock based compensation under ASC 718 “ Compensation – Stock Compensation We use the fair value method for equity instruments granted to non-employees and use the Black-Scholes model for measuring the fair value of options. The stock based fair value compensation is determined as of the date of the grant or the date at which the performance of the services is completed (measurement date) and is recognized over the vesting periods. Inventories The Company’s inventories represent finished goods, consist of products available for sale and are accounted for using the first-in, first-out (FIFO) method and valued at the lower of cost or net realizable value. Inventory consists of finished goods for the Company’s New World Health Brands business. Property and Equipment Property and equipment are recorded at cost. Minor additions and renewals are expensed in the year incurred. Major additions and renewals are capitalized and depreciated over their estimated useful lives. Depreciation is calculated using the straight-line method over the estimated useful lives. Estimated useful lives of major depreciable assets are as follows: SCHEDULE OF ESTIMATED USEFUL LIFE OF PROPERTY AND EQUIPMENT Leasehold improvements 3 years Furniture and fixtures 7 years Website costs 3 years Computer Equipment 5 years Concentrations of Credit Risk Financial instruments and related items, which potentially subject the Company to concentrations of credit risk, consist primarily of cash, cash equivalents and receivables. The Company places its cash and temporary cash investments with high credit quality institutions. At times, such investments may be in excess of the FDIC insurance limit. Net Loss Per Share The Company uses ASC 260-10, “ Earnings Per Share, At April 30, 2022 and 2021 42 847,866 10,397,258 807,866 Derivative Liabilities The Company assessed the classification of its derivative financial instruments as of April 30, 2022 and 2021 which consist of convertible instruments and rights to shares of the Company’s common stock, and determined that such derivatives meet the criteria for liability classification under ASC 815. ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as freestanding derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described. Convertible Instruments The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with professional standards for “ Accounting for Derivative Instruments and Hedging Activities The Company accounts for convertible instruments (when it has determined that the embedded conversion options should not be bifurcated from their host instruments) in accordance with professional standards when “ Accounting for Convertible Securities with Beneficial Conversion Features Reclassifications Certain reclassifications have been made to conform to prior periods’ data to the current presentation. These reclassifications had no effect on reported losses. Recent Accounting Pronouncements In March 2019, the FASB issued ASU 2019-09, “ Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting In August 2014, the FASB issued ASU 2014-15, “ Presentation of Financial Statements - Going Concern (Topic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern The FASB issued the following accounting standard updates related to Topic 606, Revenue Contracts with Customers: ● ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606) ● ASU No. 2018-08, Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net) ● ASU No. 2018-10, Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing ● ASU No. 2018-11, Revenue Recognition (Topic 605) and Derivatives and Hedging (Topic 815): Rescission of SEC Guidance Because of Accounting Standards Updates ● ASU No. 2018-12, Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients These ASUs became effective for the Company beginning interim period beginning May 1, 2018. Adoption of this standard did not have a material impact on the Company’s consolidated financial statements. In February 2016, the FASB issued Accounting Standards Update No. 2016-02 Leases Leases A variety of proposed or otherwise potential accounting standards are currently under study by standard setting organizations and various regulatory agencies. Due to the tentative and preliminary nature of those proposed standards, we have not determined whether implementation of such proposed standards would be material to our consolidated financial statements.

GOING CONCERN MATTERS

GOING CONCERN MATTERS	12 Months Ended
	Apr. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
GOING CONCERN MATTERS	NOTE B – GOING CONCERN MATTERS The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As shown in the accompanying consolidated financial statements, the Company has incurred recurring losses and generated negative cash flows from operating activities since inception. As of April 30, 2022, the Company had an accumulated deficit of $ 73,984,686 19,327,286 The Company’s existence is dependent upon management’s ability to develop profitable operations. Management is devoting substantially all of its efforts to developing its business and raising capital and there can be no assurance that the Company’s efforts will be successful. No assurance can be given that management’s actions will result in profitable operations or the resolution of its liquidity problems. The accompanying consolidated financial statements do not include any adjustments that might result should the Company be unable to continue as a going concern. In order to improve the Company’s liquidity, the Company’s management is actively pursuing additional equity financing through discussions with investment bankers, private equity groups, and private investors. There can be no assurance that the Company will be successful in its effort to secure additional equity financing.

NOTES PAYABLE AND DERIVATIVES

NOTES PAYABLE AND DERIVATIVES	12 Months Ended
	Apr. 30, 2022
Debt Disclosure [Abstract]
NOTES PAYABLE AND DERIVATIVES	NOTE C – NOTES PAYABLE AND DERIVATIVES The Company has outstanding numerous notes payable to various parties. The notes bear interest at rates of 5 20 SCHEDULE OF NOTES PAYABLE Notes Payable April 30, 2022 April 30, 2021 Notes convertible at holder’s option $ 2,980,848 $ 2,522,925 Notes convertible at Company’s option 335,700 335,700 Non-convertible notes payable 1,933,536 1,821,650 Subtotal 5,250,084 4,680,275 Less debt discount - - Total $ 5,250,084 $ 4,680,275 Certain of the notes payable contain variable conversion rates and the conversion features are classified as derivative liabilities. The conversion prices are based on the market price of the Company’s common stock, at discounts of 30 48 Amortization of debt discount for the years ended April 30, 2022 and 2021 was $ 0 0 The Company’s derivative financial instruments consist of embedded derivatives related to the outstanding short term Convertible Notes Payable. These embedded derivatives include certain conversion features indexed to the Company’s common stock. The accounting treatment of derivative financial instruments requires that the Company record the derivatives and related items at their fair values as of the inception date of the Convertible Notes Payable and at fair value as of each subsequent balance sheet date. In addition, under the provisions of Accounting Standards Codification subtopic 815-40, Derivatives and Hedging; Contracts in Entity’s Own Equity The change in fair value of the derivative liabilities of convertible notes outstanding at April 30, 2022 and 2021 was calculated with the following average assumptions, using a Black-Scholes option-pricing model are as follows: SCHEDULE OF DERIVATIVE LIABILITIES ASSUMPTIONS USING BLACK-SCHOLES OPTION Significant Assumptions: Risk free interest rate Ranging from 0.16 0.20 Expected stock price volatility 369 % Expected dividend payout 0 Expected options life in years Ranging from 1 2 Changes in derivative liability during the years ended April 30, 2022 and 2021 were: SCHEDULE OF CHANGES IN DERIVATIVE LIABILITIES April 30, 2022 2021 Balance, beginning of year $ 4,252,446 $ 2,802,125 Derivative liability reclassified to additional paid in capital (474,420 ) (573,397 ) Derivative financial liability arising on the issue of convertible notes and warrants 715,411 Fair value adjustments 3,728,206 1,310,307 Balance, end of year $ 7,506,232 $ 4,252,446

LOANS PAYABLE TO RELATED PARTIE

LOANS PAYABLE TO RELATED PARTIES	12 Months Ended
	Apr. 30, 2022
Related Party Transactions [Abstract]
LOANS PAYABLE TO RELATED PARTIES	NOTE D – LOANS PAYABLE TO RELATED PARTIES As of April 30, 2022, and 2021, aggregated loans payable, without demand and with no interest, to officers and directors were $ 432,403 432,403

EQUITY TRANSACTIONS

EQUITY TRANSACTIONS	12 Months Ended
	Apr. 30, 2022
Equity [Abstract]
EQUITY TRANSACTIONS	NOTE E EQUITY TRANSACTIONS Common Stock The Company is authorized to issue 750,000,000 0.001 On December 30, 2020, Sparta Commercial Services, Inc. (the “Company”) filed with the Secretary of State of the state of Nevada, a Certificate of Amendment to its Articles of Incorporation (the “Amendment”), attached herewith as Exhibit 3.1, and incorporated by reference. The Amendment will be effective as of December 30, 2020. On July 9, 2020, the Board of Directors of the Company declared July 30, 2020 as the effective date for the 1 for 100 reverse stock split As a result of the Reverse Stock Split, every one hundred shares of outstanding common stock will automatically be converted into one shares of the Company’s common stock immediately prior to the opening of trading on the next business day after the Effective Date. If, as a result of the reverse split, a stockholder is left with a fractional share, that stockholder shall receive one full share in lieu of such fractional share. Immediately after the effectiveness of the reverse split, there will be 7,027,930 The Company had 15,125,005 and 9,809,877 shares (post-split) of common stock issued and outstanding as of April 30, 2022 and 2021, respectively. The Company had 8,916,805 and 1,214,528 shares of common classified as to be issued at April 30, 2022 and April 30, 2021, respectively. Preferred Stock The Company is authorized to issue 10,000,000 0.001 35,850 100 1,000 10,000 4,200,000 10 2,000,000 1 As of April 30, 2022, and 2021 the Company had: SCHEDULE OF PREFERRED STOCK OUTSTANDING SHARES Preferred stock outstanding shares 2022 2021 Series A 125 125 Series B - - Series C 2,163,000 4,132,269 Series D 618,411 1,493,962 Preferred Stock Equity Transactions During the year ended April 30, 2022 the Company: ● Issued 731,623 159,010 ● Issued 3,305,860 1,010,703 ● Issued 650,076 162,519 ● Sold to fourteen accredited investors 8,563,531 shares of common stock for cash or conversions of $ 644,968 ; ● Sold to three accredited investors 520,000 130,000 ● On January 3, 2022, entered into agreements with Anthony L. Havens, the Company’s Chief Executive Officer (“Havens”) and Sandra L. Ahman, the Company’s Vice-President of Operations (“Ahman”) whereby Havens and Ahman agreed to convert debt owed to them in exchange for non-qualified stock options. ● Havens agreed to convert $ 137,465.76 1,718,322 ● Ahman agreed to convert $ 125,000 1,562,500 ● On January 3, 2022, the Company granted to each of its two independent Directors five year 187,500 0.08 three years ● On January 3, 2022, the Company granted its CEO, Anthony L Havens and Vice President of Operations, Sandra L Ahman, five year 750,000 0.08 three years ● On January 3, 2022, the Company granted to four employees, five year 437,500 0.08 three years During the year ended April 30, 2021, the Company: ● Sold 140,000 70,000 ● Issued 311,378 311,378 ● Issued 50,455 50,455 ● Pursuant to agreement, issued 250,000 50,000 ● Pursuant to Conversions of Preferred Series D convertible preferred stock, issued 890,540 222,635 ● Pursuant to Conversions of Preferred Series C convertible preferred stock, issued 2,086,848 231,872 ● Pursuant to agreement, issued 3,000,000 6,000

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	12 Months Ended
	Apr. 30, 2022
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	NOTE F – FAIR VALUE MEASUREMENTS The Company follows the guidance established pursuant to ASC 820 which established a framework for measuring fair value and expands disclosure about fair value measurements. ASC 820 defines fair value as the amount that would be received for an asset or paid to transfer a liability (i.e., an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes the following three levels of inputs that may be used: Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets and liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs. Level 2: Observable prices that are based on inputs not quoted on active markets but corroborated by market data. Level 3: Unobservable inputs when there is little or no market data available, thereby requiring an entity to develop its own assumptions. The fair value hierarchy gives the lowest priority to Level 3 inputs. The table below summarizes the fair values of financial liabilities as of April 30, 2022: SCHEDULE OF FAIR VALUES OF FINANCIAL LIABILITIES Fair Value at Fair Value Measurement Using April 30, 2022 Level 1 Level 2 Level 3 Derivative liabilities $ 9,549,640 - - $ 9,549,640 Fair values of financial liabilities as of April 30, 2021 are as follows: Fair Value at Fair Value Measurement Using April 30, 2021 Level 1 Level 2 Level 3 Derivative liabilities  $ 4,252,466 - - $ 4,252,466 The following is a description of the valuation methodologies used for these items: Derivative liabilities The Company did not identify any other non-recurring assets and liabilities that are required to be presented in the balance sheets at fair value in accordance with ASC Topic 825 “The Fair Value Option for Financial Issuances”.

PROPERTY AND EQUIPMENT

PROPERTY AND EQUIPMENT	12 Months Ended
	Apr. 30, 2022
Property, Plant and Equipment [Abstract]
PROPERTY AND EQUIPMENT	NOTE G - PROPERTY AND EQUIPMENT Major classes of property and equipment at April 30, 2022 and 2021 consist of the followings: SCHEDULE OF PROPERTY AND EQUIPMENT 2022 2021 Computer equipment, software and furniture $ 213,262 $ 213,262 Less: accumulated depreciation (213,262 ) (213,262 ) Net property and equipment $ - $ - All equipment are fully depreciated as of the fiscal year end April 30, 2022 and 2021. No additional investment in equipment for both fiscal year.

NOTE H _ WARRANTS_

NOTE H – WARRANTS:	12 Months Ended
	Apr. 30, 2022
Note H Warrants
NOTE H – WARRANTS:	NOTE H – WARRANTS: During the year ended April 30, 2022, the company issued a total of 4,843,322 0.17 3,801,657 228,099 The following table summarizes the changes in warrants: SCHEDULE OF WARRANTS OR RIGHTS, SHARES AUTHORIZED, BY EXERCISE PRICE RANGE Warrants Outstanding Warrants Exercisable Exercise Prices Number Outstanding Weighted Weighted Number Exercisable Weighted $ 0.3080 1,465,960 3 $ 0.3080 1,298,738 $ 0.3080 $ 0.2750 1,613,426 3 $ 0.2750 1,613,426 $ 0.2750 $ 0.0800 4,843,322 3 $ 0.0800 3,801,657 0.0800 Transactions involving stock warrants issued to non-employees are summarized as follows: SCHEDULE OF WARRANTS ACTIVITY Number Weighted Outstanding at April 30, 2020 5,310,745 $ 0.16190 Granted 2,395,380 0.17097 Canceled or expired (400 ) 0.17000 Outstanding at April 30, 2021 7,705,725 .016190 Granted - - Exercised - - Canceled or expired (216,983 ) 0.16010 Outstanding at April 30, 2022 7,922,708 $ 0.16190

INCOME TAXES

INCOME TAXES	12 Months Ended
	Apr. 30, 2022
Income Tax Disclosure [Abstract]
INCOME TAXES	NOTE I - INCOME TAXES At April 30, 2022, the Company has available for federal income tax purposes a net operating loss carry forward of approximately $ 65,338,601 2036 A reconciliation of the federal statutory income tax rate to the Company’s effective income tax rate is as follows: SCHEDULE OF RECONCILIATION OF INCOME TAX RATE Years Ended April 30, 2022 2021 Federal statutory income tax rate (21.0 )% (21.0 )% State income taxes, net of federal benefit (7.1 ) (7.1 ) Permanent differences 6.7 6.7 Change in valuation allowance 21.4 21.4 Provision for income taxes 0.0 % 0.0 % Components of deferred tax assets as of April 30, 2022 and estimated 2021 are as follows: SCHEDULE OF DEFERRED TAX ASSETS April 30, 2022 2021 Noncurrent: Net operating loss carry forward $ 14,753,877 $ 13,167,491 Valuation allowance (14,753,877 ) (13,167,491 ) Net deferred tax asset $ - $ -

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	12 Months Ended
	Apr. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE J - COMMITMENTS AND CONTINGENCIES Operating Lease Commitments Our executive offices are located in New York, NY. We have an agreement for use of office space at this location under a sub-lease which expired on July 31, 2018 5,100 Rent expense was $ 64,800 70,200 Employment and Consulting Agreements The Company does not have employment agreements with any of its non-executive employees. The Company has consulting agreements with outside contractors to provide marketing and financial advisory services. The agreements are generally for a term of 12 months from inception and renewable automatically from year to year unless either the Company or consultant terminates such engagement by written notice. The Company entered into five year employment agreements with its CEO, Anthony L Havens and Vice President of Operations, Sandra L Ahman. As part of their employment agreements, Mr. Havens received five year 37,625,574 0.00308 three years 12,541,858 0.00308 three years Litigation The Company is subject to legal proceedings and claims which arise in the ordinary course of its business. Sparta can make no representations about the potential outcome of such proceedings. As of April 30, 2022, we have not been named as parties to any further legal proceedings except as those disclosed prior and as updated below. From time to time, of course, we may become involved in further legal proceedings, which sometimes arise due to the very nature of and in the ordinary course of this business. By way of background, the Company had received notices dated April 1, 2016, May 13, 2016 and July 22, 2016 from two lenders claiming defaults relating to conversion requests of $ 8,365.00 5,000.00 55,125.00 27,500.00 With respect to the above claims, on September 22, 2016, a motion for summary judgment in lieu of complaint was filed in the Supreme Court in the State of New York: County of Kings, against the Company by a lender for the amount of $ 102,170.82 On October 26, 2018, a second lender commenced an action in the Supreme Court of the State of New York: New York County alleging damages from unpaid principal arising from a promissory note dated February 26, 2015 in the amount of $ 50,000.00

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Apr. 30, 2022
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE K – SUBSEQUENT EVENTS The Company has evaluated subsequent events for recognition and disclosure as of August 15,

SUMMARY OF ACCOUNTING POLICIES

SUMMARY OF ACCOUNTING POLICIES (Policies)	12 Months Ended
	Apr. 30, 2022
Accounting Policies [Abstract]
Business	Business Sparta Commercial Services, Inc. (“Sparta,” “we,” “us,” or the “Company”) is a Nevada corporation serving four markets. Sparta is a technology company that develops, markets and manages business websites and mobile applications (mobile apps) for smartphones and tablets. The Company also owns and manages websites which sell on-demand motorcycle, recreational vehicle, power-sport vehicle and truck title history reports for consumers, retail dealers, auction houses, insurance companies and banks/finance companies. Lastly, since 2007, Sparta has administered leasing programs nationwide for local and/or state agencies seeking to finance municipal vehicles and equipment. The Company also introduced a new business line in the rapidly expanding Hemp-CBD (cannabidiol) market. In 2016, the Company changed the name of its majority-owned subsidiary Specialty Reports, Inc., to iMobile Solutions, Inc. The new name reflects the Company’s strategic evolution and focus on the growing mobile application market domestically. Sparta’s mobile application (mobile app) offerings have broadened our base beyond our original base of vehicle dealers to include a wide range of businesses including, but not limited to, agriculture dealerships, racetracks, private clubs, country clubs, restaurants and grocery stores. We also offer a private label version of our mobile app framework to enable other businesses to offer custom apps to their customers. The Company also designs, launches, maintains, and hosts websites for businesses. We provide specific, tailored action plans for our clients’ websites that include services such as eCommerce, CRM (Customer Relationship Management) development and integration, ordering system creation and integration, SEO (search engine optimization), social media marketing, and online reviews to improve their presence online. In addition, we offer text messaging services which are vital for businesses’ marketing, retention and loyalty strategies. Our text messaging platform allows our clients to easily manage, schedule, and analyze text message performance. The Company’s vehicle history reports include Cyclechex (Motorcycle History Reports at www.cyclechex.com www.rvchecks.com www.truckchex.com Sparta also administers a Municipal Leasing Program for local and/or state agencies throughout the country who are seeking a better and more economical way to finance their essential equipment needs, including police motorcycles, cruisers, buses, fire trucks, and EMS equipment. We are continuing to expand our roster of equipment manufacturers and the types of equipment we lease. New World Health Brands, Inc. (NWHB) was formed in April 2019 as a subsidiary and new business line of Sparta Commercial Services, Inc. While anticipating, and with the passing of the 2018 Farm Bill, which resulted in the removal of hemp (CBD) from Schedule 1 of the Controlled Substances Act. Sparta’s management recognized a substantial potential business opportunity in the rapidly expanding Industrial Hemp-CBD (Cannabinol) market in the United States. During 2019-2020, management sourced, developed and lab tested 5 CBD product categories totaling 31 products, procured product packaging, labeling, implemented fulfillment and launched an on-line B2C website, www.newworldhealthcbd.com Sparta’s newest subsidiary, Sparta Crypto, Inc., www.SpartaCrypto.com Sparta’s offices are located at 555 Fifth Avenue, 14 th www.spartacommercial.com We identify our ongoing information technology business in two reporting groups: mobile apps/websites and vehicle history reports, both of which operate under our wholly owned subsidiary, iMobile Solutions, Inc. The latest product offering, via www.newworldhealthcbd.com, offering a full array of hemp-derived CBD products, is contained in our subsidiary, New World Health Brands, Inc.
Principles of Consolidation	Principles of Consolidation The consolidated financial statements include the accounts of the Company and its majority owned subsidiary. All material intercompany transactions and balances have been eliminated in consolidation. The third party ownership of the Company’s subsidiary is accounted for as noncontrolling interest in the consolidated financial statements. Changes in the noncontrolling interest are reported in the statement of stockholders’ deficit.
Estimates	Estimates The preparation of the financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates.
Revenue Recognition	Revenue Recognition During the first quarter of 2018, the Company adopted ASU 2014-09, Revenue from Contracts with Customers (Topic 606) The Company acts as a principal in its revenue transactions as the Company is the primary obligor in the transactions. Revenues from mobile app products and New World Health Brands products are generally recognized upon delivery. Revenues from History Reports are generally recognized upon delivery / download. Prepayments received from customers before delivery (if any) are recognized as deferred revenue and recognized upon delivery. The Company records deferred revenues when cash payments are received or due in advance of our performance, including amounts which are refundable. The following table presents our revenues disaggregated by revenue source: SCHEDULE OF DISAGGREGATION REVENUE 2022 2021 Year Ended April 30, 2022 2021 Information Technology $ 219,404 $ 245,675 New World Health Brands 26,065 14,056 Revenues $ 245,469 $ 259,731
Cash Equivalents	Cash Equivalents For the purpose of the accompanying financial statements, all highly liquid investments with a maturity of three months or less are considered to be cash equivalents.
Website Development Costs	Website Development Costs The Company recognizes website development costs in accordance with ASC 350-50, “Accounting for Website Development Costs.”
Fair Value Measurements	Fair Value Measurements The Company adopted ASC 820, “Fair Value Measurements .” ● Level 1 — ● Level 2 — ● Level 3 — This hierarchy requires the Company to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value. For some products or in certain market conditions, observable inputs may not always be available.
Income Taxes	Income Taxes We utilize ASC 740 “ Income Taxes The Company recognizes the impact of a tax position in the financial statements only if that position is more likely than not of being sustained upon examination by taxing authorities, based on the technical merits of the position. Our practice is to recognize interest and/or penalties related to income tax matters in income tax expense.
Stock Based Compensation	Stock Based Compensation We account for our stock based compensation under ASC 718 “ Compensation – Stock Compensation We use the fair value method for equity instruments granted to non-employees and use the Black-Scholes model for measuring the fair value of options. The stock based fair value compensation is determined as of the date of the grant or the date at which the performance of the services is completed (measurement date) and is recognized over the vesting periods.
Inventories	Inventories The Company’s inventories represent finished goods, consist of products available for sale and are accounted for using the first-in, first-out (FIFO) method and valued at the lower of cost or net realizable value. Inventory consists of finished goods for the Company’s New World Health Brands business.
Property and Equipment	Property and Equipment Property and equipment are recorded at cost. Minor additions and renewals are expensed in the year incurred. Major additions and renewals are capitalized and depreciated over their estimated useful lives. Depreciation is calculated using the straight-line method over the estimated useful lives. Estimated useful lives of major depreciable assets are as follows: SCHEDULE OF ESTIMATED USEFUL LIFE OF PROPERTY AND EQUIPMENT Leasehold improvements 3 years Furniture and fixtures 7 years Website costs 3 years Computer Equipment 5 years
Concentrations of Credit Risk	Concentrations of Credit Risk Financial instruments and related items, which potentially subject the Company to concentrations of credit risk, consist primarily of cash, cash equivalents and receivables. The Company places its cash and temporary cash investments with high credit quality institutions. At times, such investments may be in excess of the FDIC insurance limit.
Net Loss Per Share	Net Loss Per Share The Company uses ASC 260-10, “ Earnings Per Share, At April 30, 2022 and 2021 42 847,866 10,397,258 807,866
Derivative Liabilities	Derivative Liabilities The Company assessed the classification of its derivative financial instruments as of April 30, 2022 and 2021 which consist of convertible instruments and rights to shares of the Company’s common stock, and determined that such derivatives meet the criteria for liability classification under ASC 815. ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as freestanding derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.
Convertible Instruments	Convertible Instruments The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with professional standards for “ Accounting for Derivative Instruments and Hedging Activities The Company accounts for convertible instruments (when it has determined that the embedded conversion options should not be bifurcated from their host instruments) in accordance with professional standards when “ Accounting for Convertible Securities with Beneficial Conversion Features
Reclassifications	Reclassifications Certain reclassifications have been made to conform to prior periods’ data to the current presentation. These reclassifications had no effect on reported losses.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In March 2019, the FASB issued ASU 2019-09, “ Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting In August 2014, the FASB issued ASU 2014-15, “ Presentation of Financial Statements - Going Concern (Topic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern The FASB issued the following accounting standard updates related to Topic 606, Revenue Contracts with Customers: ● ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606) ● ASU No. 2018-08, Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net) ● ASU No. 2018-10, Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing ● ASU No. 2018-11, Revenue Recognition (Topic 605) and Derivatives and Hedging (Topic 815): Rescission of SEC Guidance Because of Accounting Standards Updates ● ASU No. 2018-12, Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients These ASUs became effective for the Company beginning interim period beginning May 1, 2018. Adoption of this standard did not have a material impact on the Company’s consolidated financial statements. In February 2016, the FASB issued Accounting Standards Update No. 2016-02 Leases Leases A variety of proposed or otherwise potential accounting standards are currently under study by standard setting organizations and various regulatory agencies. Due to the tentative and preliminary nature of those proposed standards, we have not determined whether implementation of such proposed standards would be material to our consolidated financial statements.

SUMMARY OF ACCOUNTING POLICIE_2

SUMMARY OF ACCOUNTING POLICIES (Tables)	12 Months Ended
	Apr. 30, 2022
Accounting Policies [Abstract]
SCHEDULE OF DISAGGREGATION REVENUE	The following table presents our revenues disaggregated by revenue source: SCHEDULE OF DISAGGREGATION REVENUE 2022 2021 Year Ended April 30, 2022 2021 Information Technology $ 219,404 $ 245,675 New World Health Brands 26,065 14,056 Revenues $ 245,469 $ 259,731
SCHEDULE OF ESTIMATED USEFUL LIFE OF PROPERTY AND EQUIPMENT	SCHEDULE OF ESTIMATED USEFUL LIFE OF PROPERTY AND EQUIPMENT Leasehold improvements 3 years Furniture and fixtures 7 years Website costs 3 years Computer Equipment 5 years

NOTES PAYABLE AND DERIVATIVES (

NOTES PAYABLE AND DERIVATIVES (Tables)	12 Months Ended
	Apr. 30, 2022
Debt Disclosure [Abstract]
SCHEDULE OF NOTES PAYABLE	The Company has outstanding numerous notes payable to various parties. The notes bear interest at rates of 5 20 SCHEDULE OF NOTES PAYABLE Notes Payable April 30, 2022 April 30, 2021 Notes convertible at holder’s option $ 2,980,848 $ 2,522,925 Notes convertible at Company’s option 335,700 335,700 Non-convertible notes payable 1,933,536 1,821,650 Subtotal 5,250,084 4,680,275 Less debt discount - - Total $ 5,250,084 $ 4,680,275
SCHEDULE OF DERIVATIVE LIABILITIES ASSUMPTIONS USING BLACK-SCHOLES OPTION	The change in fair value of the derivative liabilities of convertible notes outstanding at April 30, 2022 and 2021 was calculated with the following average assumptions, using a Black-Scholes option-pricing model are as follows: SCHEDULE OF DERIVATIVE LIABILITIES ASSUMPTIONS USING BLACK-SCHOLES OPTION Significant Assumptions: Risk free interest rate Ranging from 0.16 0.20 Expected stock price volatility 369 % Expected dividend payout 0 Expected options life in years Ranging from 1 2
SCHEDULE OF CHANGES IN DERIVATIVE LIABILITIES	Changes in derivative liability during the years ended April 30, 2022 and 2021 were: SCHEDULE OF CHANGES IN DERIVATIVE LIABILITIES April 30, 2022 2021 Balance, beginning of year $ 4,252,446 $ 2,802,125 Derivative liability reclassified to additional paid in capital (474,420 ) (573,397 ) Derivative financial liability arising on the issue of convertible notes and warrants 715,411 Fair value adjustments 3,728,206 1,310,307 Balance, end of year $ 7,506,232 $ 4,252,446

EQUITY TRANSACTIONS (Tables)

EQUITY TRANSACTIONS (Tables)	12 Months Ended
	Apr. 30, 2022
Equity [Abstract]
SCHEDULE OF PREFERRED STOCK OUTSTANDING SHARES	As of April 30, 2022, and 2021 the Company had: SCHEDULE OF PREFERRED STOCK OUTSTANDING SHARES Preferred stock outstanding shares 2022 2021 Series A 125 125 Series B - - Series C 2,163,000 4,132,269 Series D 618,411 1,493,962 Preferred Stock

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	12 Months Ended
	Apr. 30, 2022
Fair Value Disclosures [Abstract]
SCHEDULE OF FAIR VALUES OF FINANCIAL LIABILITIES	The table below summarizes the fair values of financial liabilities as of April 30, 2022: SCHEDULE OF FAIR VALUES OF FINANCIAL LIABILITIES Fair Value at Fair Value Measurement Using April 30, 2022 Level 1 Level 2 Level 3 Derivative liabilities $ 9,549,640 - - $ 9,549,640 Fair values of financial liabilities as of April 30, 2021 are as follows: Fair Value at Fair Value Measurement Using April 30, 2021 Level 1 Level 2 Level 3 Derivative liabilities  $ 4,252,466 - - $ 4,252,466

PROPERTY AND EQUIPMENT (Tables)

PROPERTY AND EQUIPMENT (Tables)	12 Months Ended
	Apr. 30, 2022
Property, Plant and Equipment [Abstract]
SCHEDULE OF PROPERTY AND EQUIPMENT	Major classes of property and equipment at April 30, 2022 and 2021 consist of the followings: SCHEDULE OF PROPERTY AND EQUIPMENT 2022 2021 Computer equipment, software and furniture $ 213,262 $ 213,262 Less: accumulated depreciation (213,262 ) (213,262 ) Net property and equipment $ - $ -

NOTE H _ WARRANTS_ (Tables)

NOTE H – WARRANTS: (Tables)	12 Months Ended
	Apr. 30, 2022
Note H Warrants
SCHEDULE OF WARRANTS OR RIGHTS, SHARES AUTHORIZED, BY EXERCISE PRICE RANGE	The following table summarizes the changes in warrants: SCHEDULE OF WARRANTS OR RIGHTS, SHARES AUTHORIZED, BY EXERCISE PRICE RANGE Warrants Outstanding Warrants Exercisable Exercise Prices Number Outstanding Weighted Weighted Number Exercisable Weighted $ 0.3080 1,465,960 3 $ 0.3080 1,298,738 $ 0.3080 $ 0.2750 1,613,426 3 $ 0.2750 1,613,426 $ 0.2750 $ 0.0800 4,843,322 3 $ 0.0800 3,801,657 0.0800
SCHEDULE OF WARRANTS ACTIVITY	Transactions involving stock warrants issued to non-employees are summarized as follows: SCHEDULE OF WARRANTS ACTIVITY Number Weighted Outstanding at April 30, 2020 5,310,745 $ 0.16190 Granted 2,395,380 0.17097 Canceled or expired (400 ) 0.17000 Outstanding at April 30, 2021 7,705,725 .016190 Granted - - Exercised - - Canceled or expired (216,983 ) 0.16010 Outstanding at April 30, 2022 7,922,708 $ 0.16190

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Apr. 30, 2022
Income Tax Disclosure [Abstract]
SCHEDULE OF RECONCILIATION OF INCOME TAX RATE	A reconciliation of the federal statutory income tax rate to the Company’s effective income tax rate is as follows: SCHEDULE OF RECONCILIATION OF INCOME TAX RATE Years Ended April 30, 2022 2021 Federal statutory income tax rate (21.0 )% (21.0 )% State income taxes, net of federal benefit (7.1 ) (7.1 ) Permanent differences 6.7 6.7 Change in valuation allowance 21.4 21.4 Provision for income taxes 0.0 % 0.0 %
SCHEDULE OF DEFERRED TAX ASSETS	Components of deferred tax assets as of April 30, 2022 and estimated 2021 are as follows: SCHEDULE OF DEFERRED TAX ASSETS April 30, 2022 2021 Noncurrent: Net operating loss carry forward $ 14,753,877 $ 13,167,491 Valuation allowance (14,753,877 ) (13,167,491 ) Net deferred tax asset $ - $ -

SCHEDULE OF DISAGGREGATION REVE

SCHEDULE OF DISAGGREGATION REVENUE (Details) - USD ($)	12 Months Ended
	Apr. 30, 2022	Apr. 30, 2021
Product Information [Line Items]
Revenues	$ 245,469	$ 259,731
Information Technology [Member]
Product Information [Line Items]
Revenues	219,404	245,675
New World Health Brands [Member]
Product Information [Line Items]
Revenues	$ 26,065	$ 14,056

SCHEDULE OF ESTIMATED USEFUL LI

SCHEDULE OF ESTIMATED USEFUL LIFE OF PROPERTY AND EQUIPMENT (Details)	12 Months Ended
	Apr. 30, 2022
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Computer Equipment	3 years
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Computer Equipment	7 years
Website Costs [Member]
Property, Plant and Equipment [Line Items]
Computer Equipment	3 years
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Computer Equipment	5 years

SUMMARY OF ACCOUNTING POLICIE_3

SUMMARY OF ACCOUNTING POLICIES (Details Narrative) - shares	12 Months Ended
	Apr. 30, 2022	Apr. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	42,000,000	10,397,258
Shares to be Issued [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	847,866	807,866

GOING CONCERN MATTERS (Details

GOING CONCERN MATTERS (Details Narrative) - USD ($)	Apr. 30, 2022	Apr. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Retained earnings (accumulated deficit)	$ 73,984,686	$ 64,993,250
Working capital deficit	$ 19,327,286

SCHEDULE OF NOTES PAYABLE (Deta

SCHEDULE OF NOTES PAYABLE (Details) - USD ($)	Apr. 30, 2022	Apr. 30, 2021
Short-Term Debt [Line Items]
Subtotal	$ 5,250,084	$ 4,680,275
Less debt discount
Total	5,250,084	4,680,275
Notes Convertible At Holders Option [Member]
Short-Term Debt [Line Items]
Subtotal	2,980,848	2,522,925
Notes Convertible At Companys Option [Member]
Short-Term Debt [Line Items]
Subtotal	335,700	335,700
Non Convertible Notes Payable [Member]
Short-Term Debt [Line Items]
Subtotal	$ 1,933,536	$ 1,821,650

SCHEDULE OF DERIVATIVE LIABILIT

SCHEDULE OF DERIVATIVE LIABILITIES ASSUMPTIONS USING BLACK-SCHOLES OPTION (Details)	12 Months Ended
	Apr. 30, 2022	Apr. 30, 2021
Measurement Input, Risk Free Interest Rate [Member] | Minimum [Member]
Debt Instrument [Line Items]
Derivative liability, measurement input, percentage	0.16	0.16
Measurement Input, Risk Free Interest Rate [Member] | Maximum [Member]
Debt Instrument [Line Items]
Derivative liability, measurement input, percentage	0.20	0.20
Measurement Input, Price Volatility [Member]
Debt Instrument [Line Items]
Derivative liability, measurement input, percentage	369	369
Measurement Input Dividend Payout [Member]
Debt Instrument [Line Items]
Derivative liability, measurement input, percentage	0	0
Measurement Input, Expected Term [Member] | Minimum [Member]
Debt Instrument [Line Items]
Derivative liability, measurement input, expected life	1 year	1 year
Measurement Input, Expected Term [Member] | Maximum [Member]
Debt Instrument [Line Items]
Derivative liability, measurement input, expected life	2 years	2 years

SCHEDULE OF CHANGES IN DERIVATI

SCHEDULE OF CHANGES IN DERIVATIVE LIABILITIES (Details) - USD ($)	12 Months Ended
	Apr. 30, 2022	Apr. 30, 2021
Debt Disclosure [Abstract]
Balance, beginning of year	$ 4,252,446	$ 2,802,125
Derivative liability reclassified to additional paid in capital	(474,420)	(573,397)
Derivative financial liability arising on the issue of convertible notes and warrants		715,411
Fair value adjustments	3,728,206	1,310,307
Balance, end of year	$ 7,506,232	$ 4,252,446

NOTES PAYABLE AND DERIVATIVES_2

NOTES PAYABLE AND DERIVATIVES (Details Narrative) - USD ($)	12 Months Ended
	Apr. 30, 2022	Apr. 30, 2021	Apr. 30, 2020
Debt Instrument [Line Items]
Amortization of debt discount	$ 0		$ 0
Minimum [Member]
Debt Instrument [Line Items]
Common stock discount rate, percentage	30%
Maximum [Member]
Debt Instrument [Line Items]
Common stock discount rate, percentage	48%

LOANS PAYABLE TO RELATED PART_2

LOANS PAYABLE TO RELATED PARTIES (Details Narrative) - USD ($)	Apr. 30, 2022	Apr. 30, 2021
Related Party Transactions [Abstract]
Loans payable to officers and directors	$ 432,403	$ 432,403

SCHEDULE OF PREFERRED STOCK OUT

SCHEDULE OF PREFERRED STOCK OUTSTANDING SHARES (Details) - shares	Apr. 30, 2022	Apr. 30, 2021
Series A Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock	125	125
Series B Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock
Series C Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock	2,163,000	4,132,269
Series D Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock	618,411	1,493,962

EQUITY TRANSACTIONS (Details Na

EQUITY TRANSACTIONS (Details Narrative) - USD ($)			12 Months Ended
	Jan. 03, 2022	Jul. 30, 2020	Apr. 30, 2022	Apr. 30, 2021
Class of Stock [Line Items]
Common stock, shares authorized			750,000,000	750,000,000
Common stock, par value			$ 0.001	$ 0.001
Stockholders' equity, reverse stock split		the effective date for the 1 for 100 reverse stock split
Issuance of shares, reverse stock splits			7,027,930
Common Stock, Shares, Outstanding			15,128,005	9,809,877
Common Stock, Shares Subscribed but Unissued			8,916,805	1,214,528
Preferred stock, shares designated			10,000,000	10,000,000
Preferred stock, par value			$ 0.001	$ 0.001
Issuance of stock for service, value			$ 159,011	$ 25,319
Convertion of convertible securities, value			$ 25,000	$ 50,000
Common Stock One [Member]
Class of Stock [Line Items]
Issuance of stock for service, shares			731,623
Issuance of stock for service, value			$ 159,010
Issuance of stock, shares				250,000
Issuance of stock, values				$ 50,000
Common Stock [Member]
Class of Stock [Line Items]
Issuance of stock for service, shares			731,623	126,595
Issuance of stock for service, value			$ 732	$ 127
Convertion of convertible securities, shares			125,000	250,000
Convertion of convertible securities, value			$ 125	$ 250
Common Stock [Member] | Havens Stock Option Agreement [Member]
Class of Stock [Line Items]
Convertion of deferred salary			$ 137,465.76
Stock option, grants			1,718,322
Common Stock [Member] | Ahman Stock Option Agreement [Member]
Class of Stock [Line Items]
Convertion of deferred salary			$ 125,000
Stock option, grants			1,562,500
Common Stock [Member] | Fourteen Accredited Investors [Member]
Class of Stock [Line Items]
Number of stocks sold during period			8,563,531
Sale of stock			$ 644,968
Common Stock [Member] | Three Accredited Investors [Member]
Class of Stock [Line Items]
Number of stocks sold during period			520,000
Sale of stock			$ 130,000
Common Stock [Member] | Two Independent Director [Member]
Class of Stock [Line Items]
Stock option, grants	187,500
Contractual term	5 years
Share Price	$ 0.08
Share based compensation vesting period	3 years
Common Stock [Member] | Chief Executive Officer And Vice President [Member]
Class of Stock [Line Items]
Stock option, grants	750,000
Contractual term	5 years
Share Price	$ 0.08
Share based compensation vesting period	3 years
Common Stock [Member] | Four Employees [Member]
Class of Stock [Line Items]
Stock option, grants	437,500
Contractual term	5 years
Share Price	$ 0.08
Share based compensation vesting period	3 years
Common Stock Two [Member]
Class of Stock [Line Items]
Issuance of stock, shares				3,000,000
Issuance of stock, values				$ 6,000
Series A convertible preferred stock [Member]
Class of Stock [Line Items]
Preferred stock, shares designated			35,850	35,850
Preferred stock, par value			$ 100	$ 100
Series B convertible preferred stock [Member]
Class of Stock [Line Items]
Preferred stock, shares designated			1,000	1,000
Preferred stock, par value			$ 0.001	$ 0.001
Preferred stock, liquidation and redemption value per share			$ 10,000	$ 10,000
Series C Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares designated			4,200,000
Common shares issued upon conversion			3,305,860
Converted common shares			1,010,703
Series C redeemable convertible preferred stock [Member]
Class of Stock [Line Items]
Preferred stock, shares designated			200,000	200,000
Preferred stock, par value			$ 0.001	$ 0.001
Preferred stock, liquidation and redemption value per share			$ 10	$ 10
Series D redeemable convertible preferred stock [Member]
Class of Stock [Line Items]
Preferred stock, shares designated			2,000,000	2,000,000
Preferred stock, par value			$ 0.001	$ 0.001
Preferred stock, liquidation and redemption value per share			$ 1	$ 1
Series D Preferred Stock [Member]
Class of Stock [Line Items]
Common shares issued upon conversion			650,076
Converted common shares			162,519
Series C Convertible Preferred Stock [Member]
Class of Stock [Line Items]
Number of stocks sold during period				140,000
Sale of stock				$ 70,000
Convertion of convertible securities, shares			2,086,848
Convertion of convertible securities, value			$ 231,872
Series D Convertible Preferred Stock [Member]
Class of Stock [Line Items]
Issuance of stock, shares				50,455
Issuance of stock, values				$ 50,455
Convertion of convertible securities, shares			890,540
Convertion of convertible securities, value			$ 222,635
Series D Convertible Preferred Stock [Member] | Settlement of Accounts Payable [Member]
Class of Stock [Line Items]
Issuance of stock, shares				311,378
Issuance of stock, values				$ 311,378
Post Split [Member]
Class of Stock [Line Items]
Common Stock, Shares, Outstanding			15,125,005	9,809,877

SCHEDULE OF FAIR VALUES OF FINA

SCHEDULE OF FAIR VALUES OF FINANCIAL LIABILITIES (Details) - USD ($)	Apr. 30, 2022	Apr. 30, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities	$ 9,549,640	$ 3,446,738
Derivative liabilities		4,252,466
Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities
Derivative liabilities
Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities
Derivative liabilities
Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities	$ 9,549,640
Derivative liabilities		$ 4,252,466

SCHEDULE OF PROPERTY AND EQUIPM

SCHEDULE OF PROPERTY AND EQUIPMENT (Details) - USD ($)	Apr. 30, 2022	Apr. 30, 2021
Property, Plant and Equipment [Line Items]
Less: accumulated depreciation	$ (213,262)	$ (213,262)
Net property and equipment
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Computer equipment, software and furniture	$ 213,262	$ 213,262

SCHEDULE OF WARRANTS OR RIGHTS,

SCHEDULE OF WARRANTS OR RIGHTS, SHARES AUTHORIZED, BY EXERCISE PRICE RANGE (Details)	12 Months Ended
	Apr. 30, 2022 $ / shares shares
Warrant One [Member]
Warrants outstanding, exercise price	$ 0.3080
Warrants outstanding, number | shares	1,465,960
Warrants outstanding, weighted average remaining contractual life (years)	3 years
Warrants outstanding, weighted average exercise price	$ 0.3080
Warrants exercisable, number exercisable | shares	1,298,738
Warrants exercisable, weighted average exercise price	$ 0.3080
Warrant Two [Member]
Warrants outstanding, exercise price	$ 0.2750
Warrants outstanding, number | shares	1,613,426
Warrants outstanding, weighted average remaining contractual life (years)	3 years
Warrants outstanding, weighted average exercise price	$ 0.2750
Warrants exercisable, number exercisable | shares	1,613,426
Warrants exercisable, weighted average exercise price	$ 0.2750
Warrant Three [Member]
Warrants outstanding, exercise price	$ 0.0800
Warrants outstanding, number | shares	4,843,322
Warrants outstanding, weighted average remaining contractual life (years)	3 years
Warrants outstanding, weighted average exercise price	$ 0.0800
Warrants exercisable, number exercisable | shares	3,801,657
Warrants exercisable, weighted average exercise price	$ 0.0800

SCHEDULE OF WARRANTS ACTIVITY (

SCHEDULE OF WARRANTS ACTIVITY (Details) - Warrant [Member] - Non-Employees [Member] - $ / shares	12 Months Ended
	Apr. 30, 2022	Apr. 30, 2021
Number of shares, warrants outstanding, beginning balance	7,705,725	5,310,745
Weighted average exercise price per share, warrants outstanding, beginning balance	$ 0.16190	$ 0.016190
Number of shares, warrants grants		2,395,380
Weighted average exercise price per share, warrants grants		$ 0.17097
Number of shares, warrants canceled or expired	(216,983)	(400)
Weighted average exercise price per share, warrants canceled or expired	$ 0.16010	$ 0.17000
Weighted average exercise price per share, warrants outstanding, beginning balance	$ 0.016190	$ 0.16190
Number of shares, warrants exercised
Weighted average exercise price per share, warrants exercised
Number of shares, warrants outstanding, ending balance	7,922,708	7,705,725
Weighted average exercise price per share, warrants outstanding, ending balance	$ 0.16190	$ 0.016190

NOTE H _ WARRANTS_ (Details Nar

NOTE H – WARRANTS: (Details Narrative) - Warrant [Member]	12 Months Ended
	Apr. 30, 2022 USD ($) $ / shares shares
Stock issued for services	4,843,322
Stock option price per share | $ / shares	$ 0.17
Warrants vested	3,801,657
Fair value adjustment of warrants | $	$ 228,099

SCHEDULE OF RECONCILIATION OF I

SCHEDULE OF RECONCILIATION OF INCOME TAX RATE (Details)	12 Months Ended
	Apr. 30, 2022	Apr. 30, 2021
Income Tax Disclosure [Abstract]
Federal statutory income tax rate	(21.00%)	(21.00%)
State income taxes, net of federal benefit	(7.10%)	(7.10%)
Permanent differences	6.70%	6.70%
Change in valuation allowance	21.40%	21.40%
Provision for income taxes	0%	0%

SCHEDULE OF DEFERRED TAX ASSETS

SCHEDULE OF DEFERRED TAX ASSETS (Details) - USD ($)	Apr. 30, 2022	Apr. 30, 2021
Income Tax Disclosure [Abstract]
Net operating loss carry forward	$ 14,753,877	$ 13,167,491
Valuation allowance	(14,753,877)	(13,167,491)
Net deferred tax asset

INCOME TAXES (Details Narrative

INCOME TAXES (Details Narrative)	12 Months Ended
	Apr. 30, 2022 USD ($)
Income Tax Disclosure [Abstract]
Operating loss carry forwards, net	$ 65,338,601
Operating loss carryforwards, expiration date	2036

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)		12 Months Ended
	Sep. 22, 2016	Apr. 30, 2022	Apr. 30, 2021	Feb. 26, 2015
Rent expenses		$ 64,800	$ 70,200
Promissory Note [Member]
Aggregate note amount				$ 50,000
New York County Kings [Member]
Loss on contingent	$ 102,170.82
Lender One [Member]
Debt principal amount		8,365
Aggregate note amount		55,125
Lender Two [Member]
Debt principal amount		5,000
Aggregate note amount		$ 27,500
Employment Agreement [Member] | Mr. Havens [Member]
Debt instrument, term		5 years
Number of shares issued during the period		37,625,574
Share price		$ 0.00308
Shares vested term		3 years
Employment Agreement [Member] | Ms. Ahman [Member]
Number of shares issued during the period		12,541,858
Share price		$ 0.00308
Shares vested term		3 years
Executive Office Space [Member]
Lease expiring date		Jul. 31, 2018
Rent expenses		$ 5,100